Physician profile
Steven Grover
NPI 1144374174
$22,703.38
in general payments reported to CMS, 2019-2025
7 companies · $30.76 in 2025
The $30.76 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.94 · 2021: $252 · 2022: $4,530 · 2023: $14K · 2024: $4,354 · 2025: $30.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $1,407 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,000.00 |
| Food and Beverage | $1,407.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,282.69 | 2021-2024 | Da Vinci Surgical System, Da Vinci Sp |
| Hologic Sales and Service, LLC | $186.79 | 2020-2021 | |
| Medtronic, INC. | $121.99 | 2022-2025 | Truclear, Interstim, Altaviva |
| Merz North America, INC. | $53.90 | 2021-2022 | |
| Axonics, INC. | $21.46 | 2024 | Bulkamid |
| Myovant Sciences INC. | $20.68 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.87 | 2025 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Grover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.